Physician profile
Katherine Rogg
NPI 1184159170
$3,200.75
in general payments reported to CMS, 2019-2025
24 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $422 · 2022: $682 · 2023: $428 · 2024: $593 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,943 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,943.49 |
| Education | $153.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $725.09 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $554.23 | 2024-2025 | |
| Abbvie INC. | $333.61 | 2021-2023 | Lo Loestrin Fe |
| Organon LLC | $230.48 | 2022-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $209.93 | 2021-2024 | Gardasil, Gardasil 9 |
| Myovant Sciences INC. | $175.41 | 2021-2022 | |
| Agile Therapeutics, INC. | $155.24 | 2021-2024 | Twirla |
| Aspira Women'S Health INC | $121.44 | 2022 | |
| Baxter Healthcare | $106.39 | 2025 | Floseal, Tisseel |
| Evofem Biosciences, INC. | $94.24 | 2022-2025 | Phexxi, Solosec, Phexx |
| Millicent US INC | $71.63 | 2024-2025 | Intrarosa, Femlyv |
| Scynexis, INC. | $63.02 | 2022 | |
| Biogen, INC. | $54.10 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $48.01 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $45.12 | 2023-2025 | Slynd |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $41.85 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Optumhealth Care Solutions, LLC | $36.97 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Bayer Healthcare Pharmaceuticals INC. | $33.50 | 2025 | |
| Therapeuticsmd, INC. | $26.30 | 2022 | |
| Pfizer INC. | $21.69 | 2023 | |
| Coopersurgical, INC. | $18.52 | 2024 | Paragard T 380a |
| Shield Therapeutics INC | $15.04 | 2022 | |
| Avion Pharmaceuticals | $12.43 | 2022 | |
| Meditrina | $6.51 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Rogg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.